Health and Healthcare Systems

COVID-19: What you need to know about the coronavirus pandemic on 16 March

Japan's Prime Minister Yoshihide Suga receives his first dose of the Pfizer-BioNtech coronavirus disease (COVID-19) vaccine at National Center for Global Health and Medicine in Tokyo, Japan March 16, 2021, in this photo released by Kyodo.

Vaccination programs continue to grow across the world, as the number of vaccine doses administered reaches 359 million. Image: REUTERS

Sam Bridgeworth
Writer, Forum Agenda
  • This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: WHO Director-General urges vaccine solidarity; US administers 109 million vaccine doses; and more European countries pause use of AstraZeneca vaccine.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have now passed 120.2 million globally, according to the Johns Hopkins Coronavirus Resource Center. The number of confirmed deaths stands at more than 2.66 million. More than 381 million vaccination doses have been administered globally, according to Our World in Data.

In a press conference on Monday, World Health Organization (WHO) epidemiologist Maria van Kerkhove, the technical lead on COVID-19, said the world has seen an 11% increase in COVID-19 cases worldwide in the past week. “It is not the time to let up [on measures],” she added.

A new coronavirus variant has been found in a cluster of cases in the Brittany region of France. The French health ministry said that initial analysis did not show this new variant to be more serious or transmissible than others.

India reported 24,492 new coronavirus cases on Tuesday, the sixth straight day of more than 20,000 infections. Total cases have now risen to 11.41 million, the highest in the world after the United States and Brazil.

The United States has administered 109,081,860 doses of COVID-19 vaccines in the country as of Monday morning, and distributed 135,847,835 doses, according to the US Centers for Disease Control and Prevention (CDC).

German coronavirus infections are spreading exponentially, up 20% in the last week, an expert at the Robert Koch Institute for infectious diseases said on Tuesday. On Monday, the number of cases per 100,000 rose to 83, up from 79 on Sunday and 68 a week ago, and the RKI has warned that metric could reach 200 by the middle of next month.

COVID-19 coronavirus daily cases
The world has seen an 11% increase in COVID-19 cases worldwide in the past week, according to WHO epidemiologist Maria van Kerkhove. Image: Our World in Data

2. WHO Director-General urges vaccine solidarity across the world

WHO Director-General Dr. Tedros Adhanom Ghebreyesus has urged countries to work together to address access to vaccines.

"The greatest threat that most countries face now is lack of access to vaccines. Almost every day, I receive calls from senior political leaders around the world, asking when their country will receive their vaccines through COVAX," he said during a WHO media briefing Monday.

"We continue to call for all countries to work in solidarity to ensure that vaccination begins in all countries within the first 100 days of this year. We have 26 days left. No country can simply vaccinate its way out of this pandemic alone. We are all in this together."

3. More countries suspend use of AstraZeneca vaccine, WHO gives reassurance

On Tuesday, Sweden and Latvia announced they are pausing the use of the AstraZeneca vaccine as a precautionary measure. They join a number of other European countries, including Germany, France and Italy.

Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots, and a low platelet count. Iceland and Bulgaria followed, and Ireland and the Netherlands announced suspensions on Sunday.

In the WHO media briefing on Monday, Chief Scientist Soumya Swaminathan reiterated that there had been no documented deaths linked to COVID-19 vaccines.

“We do not want people to panic,” she said, adding that no association had so far been found between the “thromboembolic events” reported in some countries and COVID-19 shots.

In a statement on Sunday, AstraZeneca reassured people that after a review of over 17 million people vaccinated in the EU and UK, "...there have been 15 events of DVT and 22 events of pulmonary embolism" as of 8 March.

It added that "this is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines".

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Accelerating action against breast and cervical cancer in Africa: Global women's health alliance expands to Zambia

Kennedy Lishimpi and Emily Fitzgerald

November 17, 2024

How COVID-19 unleashed a wave of medical oxygen innovation

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum